Rankings
▼
Calendar
MLTX Q2 2025 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena
MLTX
MoonLake Immunotherapeutics
$1B
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$742,000
Operating Income
-$61M
Net Income
-$55M
EPS (Diluted)
$-0.87
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$55M
Free Cash Flow
-$55M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$460M
Total Liabilities
$102M
Stockholders' Equity
$354M
Cash & Equivalents
$307M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$742,000
$0
—
Operating Income
-$61M
-$31M
-98.5%
Net Income
-$55M
-$24M
-127.6%
Revenue Segments
License
$300M
100%
← FY 2025
All Quarters
Q3 2025 →